Published in Trends Immunol on May 01, 2005
Mast cells and inflammation. Biochim Biophys Acta (2010) 1.91
Molecular mechanism of mast cell mediated innate defense against endothelin and snake venom sarafotoxin. J Exp Med (2007) 1.41
Mast cell function: a new vision of an old cell. J Histochem Cytochem (2014) 1.08
Endothelin-1 activates ETA receptors to cause reflex scratching in BALB/c mice. Br J Pharmacol (2007) 0.91
Neural peptidase endothelin-converting enzyme 1 regulates endothelin 1-induced pruritus. J Clin Invest (2014) 0.84
Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc Natl Acad Sci U S A (2008) 3.74
Seroprevalence of autoantibodies against brain antigens in health and disease. Ann Neurol (2014) 2.36
Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system. Neuron (2008) 2.27
Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet (2011) 2.21
Asymmetric dimethylarginine in response to recombinant tissue-type plasminogen activator and erythropoietin in acute stroke. Stroke (2013) 2.07
Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial. J Clin Psychiatry (2014) 2.01
Practice effects in healthy adults: a longitudinal study on frequent repetitive cognitive testing. BMC Neurosci (2010) 1.59
Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Invest Ophthalmol Vis Sci (2004) 1.44
Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis. Brain (2008) 1.40
Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics (2009) 1.36
The brain erythropoietin system and its potential for therapeutic exploitation in brain disease. J Neurosurg Anesthesiol (2006) 1.23
Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin. Brain (2005) 1.21
Cognitive and sensorimotor gating impairments in transgenic mice overexpressing the schizophrenia susceptibility gene Tcf4 in the brain. Biol Psychiatry (2010) 1.21
Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms. Arch Gen Psychiatry (2010) 1.17
Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research. Best Pract Res Clin Anaesthesiol (2010) 1.16
Erythropoietin enhances hippocampal long-term potentiation and memory. BMC Biol (2008) 1.14
The structure and usage of female and male mouse ultrasonic vocalizations reveal only minor differences. PLoS One (2012) 1.13
Mechanisms of disease: inherited demyelinating neuropathies--from basic to clinical research. Nat Clin Pract Neurol (2007) 1.12
The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patients. BMC Psychiatry (2010) 1.10
Altered cell-mediated immunity and increased postoperative infection rate in long-term alcoholic patients. Anesthesiology (2004) 1.09
Aberrant function and structure of retinal ribbon synapses in the absence of complexin 3 and complexin 4. J Cell Sci (2009) 1.05
Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis. Brain (2004) 1.04
Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. J Pineal Res (2006) 1.04
Uncoupling of neurodegeneration and gliosis in a murine model of juvenile cortical lesion. Glia (2009) 1.02
Callosal dysfunction in amyotrophic lateral sclerosis correlates with diffusion tensor imaging of the central motor system. Neuromuscul Disord (2008) 1.01
In vitro gender differences in neuronal survival on hypoxia and in 17beta-estradiol-mediated neuroprotection. J Cereb Blood Flow Metab (2005) 1.01
A CAG repeat polymorphism of KCNN3 predicts SK3 channel function and cognitive performance in schizophrenia. EMBO Mol Med (2011) 1.00
5-HT7R/G12 signaling regulates neuronal morphology and function in an age-dependent manner. J Neurosci (2012) 0.99
Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism. Behav Brain Res (2012) 0.99
Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring. Restor Neurol Neurosci (2003) 0.95
ETB receptor deficiency causes salt-sensitive hypertension. J Mol Med (Berl) (2002) 0.95
Expression patterns of erythropoietin and its receptor in the developing spinal cord and dorsal root ganglia. Anat Embryol (Berl) (2005) 0.93
Personality disorder and chronicity of addiction as independent outcome predictors in alcoholism treatment. Psychiatr Serv (2006) 0.93
A myelin gene causative of a catatonia-depression syndrome upon aging. EMBO Mol Med (2012) 0.92
Soccer, neurotrauma and amyotrophic lateral sclerosis: is there a connection? Curr Med Res Opin (2004) 0.92
Recovery of hippocampus-related functions in chronic alcoholics during monitored long-term abstinence. Alcohol Alcohol (2006) 0.92
Mild overexpression of Mecp2 in mice causes a higher susceptibility toward seizures. Am J Pathol (2013) 0.91
Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review and individual patient data meta-analysis. Acad Radiol (2013) 0.91
Substantial decrease of psychiatric comorbidity in chronic alcoholics upon integrated outpatient treatment - results of a prospective study. J Psychiatr Res (2004) 0.90
Erythropoietin: not just about erythropoiesis. Lancet (2010) 0.90
Hypoxia inducible factor stabilization leads to lasting improvement of hippocampal memory in healthy mice. Behav Brain Res (2009) 0.89
Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: impact of alcohol deterrents on outcome. Alcohol Clin Exp Res (2006) 0.89
Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression. Psychopharmacology (Berl) (2011) 0.89
Persistent alterations of vasopressin and N-terminal proatrial natriuretic peptide plasma levels in long-term abstinent alcoholics. Alcohol Clin Exp Res (2003) 0.87
Erythropoietin improves operant conditioning and stability of cognitive performance in mice. BMC Biol (2009) 0.86
A pilot study on the oral conditions of severely alcohol addicted persons. J Contemp Dent Pract (2003) 0.86
The influence of personality factors on disease progression and health-related quality of life in people with ALS. Amyotroph Lateral Scler (2008) 0.85
Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment. Curr Pharm Des (2010) 0.85
Expression of constitutively active erythropoietin receptor in pyramidal neurons of cortex and hippocampus boosts higher cognitive functions in mice. BMC Biol (2011) 0.85
Erythropoietin attenuates neurological and histological consequences of toxic demyelination in mice. Mol Med (2012) 0.85
Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder. Trials (2010) 0.84
Circadian modulation of GABA-mediated cortical inhibition. Cereb Cortex (2011) 0.84
Prediction of the risk of comorbid alcoholism in schizophrenia by interaction of common genetic variants in the corticotropin-releasing factor system. Arch Gen Psychiatry (2011) 0.83
Thrombopoietin inhibits nerve growth factor-induced neuronal differentiation and ERK signalling. Cell Signal (2007) 0.83
Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases. Neurosci Lett (2006) 0.83
Neuroinflammation in white matter tracts of Cnp1 mutant mice amplified by a minor brain injury. Glia (2013) 0.82
Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple Sclerosis. Ther Adv Neurol Disord (2008) 0.82
Mild expression differences of MECP2 influencing aggressive social behavior. EMBO Mol Med (2014) 0.82
Monogenic heritable autism gene neuroligin impacts Drosophila social behaviour. Behav Brain Res (2013) 0.82
Endothelin B receptor deficiency augments neuronal damage upon exposure to hypoxia-ischemia in vivo. Brain Res (2002) 0.81
Common variants of the genes encoding erythropoietin and its receptor modulate cognitive performance in schizophrenia. Mol Med (2012) 0.81
A phenotype-based genetic association study reveals the contribution of neuregulin1 gene variants to age of onset and positive symptom severity in schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2011) 0.81
Melatonin as a candidate compound for neuroprotection in amyotrophic lateral sclerosis (ALS): high tolerability of daily oral melatonin administration in ALS patients. J Pineal Res (2002) 0.81
Chronic psychosocial stress in the absence of social support induces pathological pre-pulse inhibition in mice. Behav Brain Res (2009) 0.80
Cell type specific signalling by hematopoietic growth factors in neural cells. Neurochem Res (2006) 0.80
Persistent disturbance of the hypothalamic-pituitary-gonadal axis in abstinent alcoholic men. Alcohol Alcohol (2003) 0.80
Outpatient Long-term Intensive Therapy for Alcoholics (OLITA): a successful biopsychosocial approach to the treatment of alcoholism. Dialogues Clin Neurosci (2007) 0.79
Effect of endothelin-1 on astrocytic protein content. Glia (2003) 0.79
Genetic markers of a Munc13 protein family member, BAIAP3, are gender specifically associated with anxiety and benzodiazepine abuse in mice and humans. Mol Med (2013) 0.79
Stromal endothelin B receptor-deficiency inhibits breast cancer growth and metastasis. Mol Cancer Ther (2009) 0.79
Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches. Mol Med (2008) 0.79
Pre-embedding immunogold labeling of TUNEL stain enables evaluation of DNA strand breaks and ultrastructural alterations in individual cells of neuronal tissue. Acta Neuropathol (2002) 0.78
Erythropoietin augments survival of glioma cells after radiation and temozolomide. Int J Radiat Oncol Biol Phys (2008) 0.78
Supervised disulfiram in the treatment of alcohol use disorder: a commentary. Alcohol Clin Exp Res (2011) 0.78
A role for prostaglandins in rapid cycling suggested by episode-specific gene expression shifts in peripheral blood mononuclear cells: a preliminary report. Bipolar Disord (2014) 0.78
Arginine challenge unravels persistent disturbances of urea cycle and gluconeogenesis in abstinent alcoholics. Alcohol Alcohol (2006) 0.78
Apolipoprotein A-I as a candidate serum marker for the response to lithium treatment in bipolar disorder. Proteomics (2010) 0.78
Fast cerebellar reflex circuitry requires synaptic vesicle priming by munc13-3. Cerebellum (2015) 0.77
Development of an outcome prediction measure for alcoholism therapy by multimodal monitoring of treatment processes. J Psychiatr Res (2008) 0.77
Preserved vasopressin response to osmostimulation despite decreased basal vasopressin levels in long-term abstinent alcoholics. Alcohol Clin Exp Res (2004) 0.77
Effects of cerebrovascular challenges on plasma endothelin. Neurosci Res (2002) 0.77
Odor naming and interpretation performance in 881 schizophrenia subjects: association with clinical parameters. BMC Psychiatry (2013) 0.76
Dr Miskowiak and colleagues reply. J Clin Psychiatry (2015) 0.75
Therapist rotation--a new element in the outpatient treatment of alcoholism. Subst Use Misuse (2004) 0.75
Hippocampal cannabinoid-1 receptor upregulation upon endothelin-B receptor deficiency: a neuroprotective substitution effect? Neurochem Res (2005) 0.75
The approximate planimetric method: a simple, rapid and reliable method for estimation of lesion size in acute ischemic stroke. Neuroradiology (2003) 0.75
[Oral condition of abstaining alcoholics. A case-control study]. Schweiz Monatsschr Zahnmed (2003) 0.75